Both in Pharmaceuticals
Gossamer Bio vs Clene
Over the past year GOSS returned −94.4% and CLNN returned −57.0%; their daily moves had a correlation of 0.01.
GOSS −94.4% CLNN −57.0%Growth of $1, one year, split-adjusted
| Metric | GOSS | CLNN |
|---|---|---|
| Price | $10.69 | $4.03 |
| Market cap | $65.4M | $57.3M |
| Today | +9.42% | +1.51% |
| 1 month | −7.7% | −1.7% |
| 6 months | −61.8% | −30.5% |
| Year to date | −95.7% | −31.3% |
| 1 year | −94.4% | −52.6% |
| Revenue growth (YoY) | −19.6% | +233.3% |
| Gross margin | 100.0% | 60.0% |
| Net margin | 182.9% | −14915.6% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 290.8× |
| Net cash | $20.9M | -$9.1M |
| Dividend yield | — | — |
| Volatility (60d) | 1,265.8% | 81.6% |
| Short % of float | 24.9% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).